ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

7.67
Delayed Data
As of Jul 27
 -0.03 / -0.39%
Today’s Change
4.90
Today|||52-Week Range
9.89
+11.64%
Year-to-Date

Today’s Trading

Previous close7.70
Today’s open7.62
Day’s range7.44 - 7.69
Volume2,245,516
Average volume (3 months)3,357,936
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)+41.61%
Earnings growth (this year)-23.10%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+131.36%
P/E ratioNM
Price/Sales12.18
Price/Book17.85

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.05-0.21%
NKTRNektar Therapeutics-0.36-2.82%
EXELExelixis Inc-0.15-2.68%
DBVTDBV Technologies SA-0.61-1.43%
Data as of 4:14pm ET, 07/27/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$105.4M
Annual profit (last year)-$162.6M
Net profit margin-154.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Harvey J. Berger
Chief Financial Officer, Treasurer &
Executive VP
Edward M. Fitzgerald
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers